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Abstract  
According to the World Health Organization, (WHO, 2017), 322 million people suffered from 
depression in 2015, representing 4.4 percent of the world's population. Predictors of 
depression would help to identify patients at risk and shorten the time for an effective 
treatment. The aim of this systematic review is to determine whether cortisol levels predict 
the development of depression in the adult population. Our analysis considered various 
methods for measuring cortisol levels (salivary, urine, hair and serum), various timepoints and 
conditions (awakening cortisol, cortisol profiles, DEX-CRH test), the use of different 
screening instruments for depression as well as different study designs. Prospective 
observational studies and interventional cohort studies were investigated. The search was 
conducted via PubMed, Medline, PsychInfo, Embase, Science direct and Web of Science 
between March and April 2015 using appropriate indexed terms. All observational and 
prospective cohort studies between 1992 and 2015 were selected if they met all of the 
predefined inclusion and none of the exclusion criteria. Studies were included according to 
the PRISMA four-phase flow diagram. The quality of primary studies was assessed using the 
quality appraisal tool “Newcastle Ottawa Scale” for observational studies and “Jadad scale” 
for interventional studies. Our main outcome measure was the incidence of depression 
defined according to ICD-10, DSM-IV or DSM-V criteria. Standardized self-rating and 
foreign-rating scales were accepted for measuring the outcome variable. From a total of 4,619 
articles in English language, we were able to identify 41 articles that met our criteria, of 
which 17 were observational studies and 24 interventional studies. Eleven observational and 
five interventional studies reported on the association between cortisol and follow-up 
depression. The present work shows that in women, elevated cortisol levels may act as a 
predictor of depression, whereas the current research situation in men is unclear. Salivary 
cortisol seems to be the most practicable measure. The best time for evaluation is “morning 
cortisol”. Measurements of the cortisol-awakening response are promising, although they are 
often not suitable because this type of measurement can be influenced by a variety of factors. 
Confirmatory studies based on our results are recommended before salivary morning cortisol 
measurements can be considered as clinical routine for predicting depression in women. 
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Abstract  
Laut der Weltgesundheitsorganisation (WHO, 2017) litten im Jahr 2015 insgesamt 322 
Millionen Menschen an Depressionen; 4,4 Prozent der Weltbevölkerung. Prädiktoren für das 
Auftreten einer Depression würden helfen Risikopatienten zu identifizieren und die Zeit für 
eine wirksame Behandlung zu verkürzen. Ziel dieses systematischen Reviews ist es 
festzustellen, ob der Cortisolspiegel die Entwicklung einer Deprression vorhersagt. In unserer 
Analyse wurden verschiedene Methoden zur Messung des Cortisolspiegels (Speichel, Urin, 
Haare und Serum), verschiedene Zeitpunkte und Bedingungen (Awakening Cortisol, 
Cortisolprofile, DEX-CRH-Test), verschiedene Screening-Instrumente für Depressionen 
sowie verschiedene Studiendesigns untersucht (prospektive Beobachtungsstudien und 
interventionelle Kohortenstudien). Die Suche wurde über PubMed, Medline, PsychInfo, 
Embase, Science direct und Web of Science zwischen März 2015 und April 2015 unter 
Verwendung geeigneter indizierter Begriffe durchgeführt. Alle beobachtenden und 
prospektiven Kohortenstudien zwischen 1992 und 2015 wurden ausgewählt, wenn sie alle 
vordefinierten Einschlusskriterien und keines der Ausschlusskriterien erfüllten. Die Studien 
wurden gemäß dem PRISMA Vierphasen Flussdiagramm aufgenommen. Die Qualität der 
Primärstudien wurde mit dem Qualitätsbewertungsinstrument "Newcastle Ottawa Scale" für 
Beobachtungsstudien und "Jadad Scale" für interventionelle Studien bewertet. Unsere 
Hauptergebnisvariable war die Inzidenz von Depressionen, definiert nach ICD-10-, DSM-IV 
oder DSM-V. Standardisierte Eigen- und Frembewertungsinstrumente wurden für die 
Messung der Ergebnisvariablen akzeptiert. Aus insgesamt 4619 Artikeln in englischer 
Sprache konnten wir 41 Artikel identifizieren, die unsere Kriterien erfüllten, darunter 17 
Beobachtungsstudien und 24 Interventionsstudien. In elf Beobachtungs- und fünf 
Interventionsstudien wurde die Assoziation von Cortisol und Depression untersucht und 
berichtet. Die vorliegende Arbeit zeigt, dass bei Frauen erhöhte Cortisolspiegel als Prädiktor 
für eine Depression dienen könnten. Die aktuelle Forschungssituation bei Männern ist unklar. 
Speichelcortisol scheint für die Messung am praktikabelsten. Die beste Zeit für eine 
Probenentnahme ist das Morgencortisol. Messungen der Cortisol „Aufwachantwort“ scheinen 
ebenfalls vielversprechend, sie sind jedoch häufig nicht geeignet, da diese Art der Messung 
durch verschiedene Faktoren beeinflusst werden kann. Bestätigende Studien sind jedoch 
empfohlen, bevor Speichel-Cortisol-Morgenmessungen bei Frauen als klinische Routine für 
die Vorhersage von Depressionen genutzt werden. 
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1 Introduction 
 
About 38% of the EU population suffers from a mental disorder. Among these 164 million 
people who are affected each year, major depression is claimed to be the most frequent 
disorder (Wittchen et al., 2011). In order improve the management of this disease or even 
prevent it, attempts have been made to identify possible predictors defining patients at risk. 
Researchers from a European consortium identified several risk factors for the development 
of depression, leading to the development of the so-called PredictD algorithm (King et al., 
2008). Predictive factors that have been identified are age, gender, level of education, 
previous depressive episodes or a familial predisposition (King et al., 2008). However, given 
that these factors are mostly unmodifiable, they do not reflect the influence of environmental 
factors such as critical lifetime events. Nonetheless, it is well known that hormonal changes 
can be observed depending on the lifetime situation.  
In detail, it was shown that there is an association of different hormones such as cortisol, 
testosterone, thyroid hormones, IGF-1, etc. with the risk of depression (Bhagwagar et al., 
2005; Giltay et al., 2012; Sievers et al., 2014). One of the most studied promising candidates 
in this context is cortisol (Velders et al., 2011), as affected patients present with abnormal 
activity of the hypothalamic-pituitary-adrenal (HPA) axis (Holsboer et al., 2000; Pariante, 
2003; Piwowarska et al., 2012). Known as a stress hormone, cortisol appears to be an 
important factor in the pathophysiology of depression, among other factors such as structural 
and functional changes in certain areas of the brain, serotonin deficiency, depression as an 
inflammatory process, the release of various hormones, etc. It is well known that an increased 
release of cortisol occurs in case of stress. Repeated stress or critical life events connected 
with a stress response and, thus, an increased release of cortisol, can lead to depression 
(Möller et al., 2009).  
Cortisol is a very susceptible hormone that can be affected by various factors between and 
within individuals (Nicholson, 2008). In cross-sectional studies it has been clearly shown that 
early morning cortisol was increased in serum in patients with depression when adjusted for 
the time of awakening (Bhagwagar et al., 2005). Scott and Dinan (1998) demonstrated in a 
small sample that urinary-free cortisol levels of depressive patients are significantly higher 
compared with healthy controls. In a study with 42 students, hair cortisol concentrations were 
associated with the presence of depressive symptoms, suggesting that hair cortisol 
measurement can also serve as a potential biomarker for this kind of mental disorder (Gerber 
et al., 2013).  
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Disturbances of hormonal axes cannot only be identified by reduced baseline levels. In 
order to identify impaired hormonal axes, suppression tests are necessary to investigate 
whether elevated baseline levels will appropriately be reduced upon suppression. In fact, 
patients with depression presented with a blunted suppression of plasma cortisol levels 
following the intake of dexamethasone indicating disturbances in HPA axis negative feedback 
regulation (Fang et al., 1981; Halbreich et al., 1985). Based on results from our institute, it has 
been suggested that altered HPA axis regulation measured by the DEX/CRH test at two 
different time points might be the best HPA axis related biomarker for predicting the clinical 
outcome at follow-up. All of these findings indicate that individual differences in cortisol 
levels as well as an altered HPA axis reactivity are possible risk factors respectively markers 
for the development of depression.  
However, there are some inconsistencies and contradictory results regarding the time, 
method and applicability of cortisol measurements. For instance, Grynderup et al. (2013) 
examined 4,231 healthy people and found a correlation between the delta in morning and 
evening salivary cortisol concentration and the risk of developing depression while this was 
not the case for morning or evening salivary cortisol levels alone. This result contradicts 
findings by Harris et al. (2000) stating that individual differences in morning salivary cortisol 
levels (but not evening salivary cortisol levels) in females can be considered a risk factor for 
major depressive disorder (Harris et al., 2000). Herbert et al. (2012) came to the conclusion 
that an association between the adjusted morning cortisol levels predicts the risk for 
depression onset during a 12-month follow-up period best. According to a recent study, high 
cortisol values determined in the late morning in women at the age 45 years are predictive for 
subsequent depressive symptoms at the age of 50 years. In men, lower instead of higher 
cortisol values were prospectively associated with the occurrence of depressive symptoms 
(Geoffroy et al., 2013).  
In conclusion, various biomaterials (salivary, urine, hair, serum) at various time points and 
under different conditions (awakening cortisol, cortisol profiles, DEX-CRH tests) and the use 
of different screening instruments for depression as well as different study designs allow no 
clear conclusion to the study question thus far. The objective of this systematic review is 
therefore to clarify whether there is an evidence-based, pragmatic way of using cortisol 
measurements as additional indicators/predictors for physicians to evaluate whether their 
patients might develop a depression in the near future or not.  
. 
2 Background                                                                                                               2.1 DEPRESSION 
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2 Background 
2.1 Depression  
The mental state of depressed persons is well described by the term “press down”, while the 
Latin word for this is deprimere (O’Toole, 2016). In everyday life, the word depression is 
often used if we do not feel well, do not feel like doing something or are sad, although 
according to Hegerl et al. (2005) it can lead to misunderstandings. because we all experience 
depressive symptoms in our lives, such as sadness or drivelessness. Often such experiences 
emerge during stressful phases of life, illness or stressful events, such as the death of a 
relative. However, these symptoms alone do not warrant the diagnosis of depression in the 
clinical sense. Being depressed does not mean being completely sad or perhaps unmotivated; 
rather, it is a disorder that can lead to impairments on the "emotional, cognitive, 
physiological, motor, social-interactive and behavioral" levels of the human body (Wittchen 
& Hoyer, 2006). 
2.1.1 Diagnose of Depression 
The notion that the diagnosis of the depression is not mistakenly awarded a clear definition is 
indispensable in view of a clear clinical diagnosis, which should be based on operationalized 
criteria. In order to guarantee this, different diagnostic manuals have been introduced in the 
past in which internationally-recognized diagnostic definitions are operationalized. The 
currently-used classification schemes are the ICD-10/ICD-11 (International Classification of 
Diseases, 10th Edition), which is predominantly used in German-speaking countries, and the 
DSM-IV/DSM V used in English-speaking countries (Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition). The former was published by the WHO (1993), the latter by 
the American Psychiatric Association (APA, 1994). In the meantime, the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders, the so-called DSM-5 (APA, 2013) has 
been published. The American Psychiatric Association released this 5th edition in May 2013 
(Ehret & Berking, 2013). In the present work, all three diagnostic systems will be considered.  
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2.1.2 The clinical picture of depression in ICD-10 
In ICD-10, the disorder of depression is listed in the diagnostic category “Affective 
Disorders”. Affective disorders are characterized by a depressed mood of unusual 
proportions, with or without fear. Its episodic occurrence is often associated with a distressing 
situation or event. The disease of depression is divided into three different degrees of severity. 
Depending on the severity, the disease is characterized by three major symptoms: 1.) 
depressed mood most of the day and almost every day 2.) loss of interest and enjoyment of 
activities and listlessness 3.) increased fatigue. In a mild or moderate depressive episode at 
least two of these symptoms must be present, in severe depression at least three. In addition, 
there are other symptoms, such as 4.) loss of trust or self-esteem 5.) unfounded self-blame or 
guilt 6.) suicidal thoughts or actions 7.) concentrations problems or indecision 8.) 
psychomotor agitation or inhibition 9.) sleep disorders 10.) appetite loss or increase. In mild 
depression, there must be at least two of these symptoms, three to four in a moderate, and at 
least four in a severe depression. Despite the patient's experience of mild depression, he can 
fulfill his professional obligations and continue to participate in social life. In the case of 
moderate depression, performing everyday activities is much more difficult for the patient, 
and in the case of severe depression, the patient is no longer able to carry out his day-to-day 
activities. In a mild or moderate depressive episode, symptoms must at least two weeks before 
the diagnosis can be given. In severe depression, this diagnosis can be given earlier, but this 
depends on the severity of the disease (Dilling, Mombour, Schmidt, 2014).  
2.1.3 The clinical picture of depression in DSM-IV 
The criteria of DSM-IV are different from those of ICD-10 in terms of clinical significance, 
duration of symptoms and severity of disease (Gruenberg, Goldstein, Pincus, 2005). In DSM-
IV there is no subdivision by severity. Due to the lack of severity classification in the DSM-
IV the diagnosis of depression can then be given, if there are five or more symptoms (Kölch, 
Fegert & Freyberger, 2011; Gruenberg, Goldstein & Pincus (2005) and the clinical 
significance is then given when the symptoms lead to “impairments in social, occupational, 
or other important areas of functioning” or if the symptoms “cause clinically significant 
distress” (Gruenberg, Goldstein & Pincus 2005; Kölch, Fegert & Freyberger, 2011). 
Furthermore, DSM-IV “feelings of worthlessness or inappropriate guilt” are listed together, 
and according to Gruenberg, Goldstein and Pincus (2005) this can be considered more serious 
in quality compared with the criterion “loss of self-confidence or self-esteem” as listed in the 
ICD-10. In both classification systems, the diagnosis of depression requires that the  
2 Background                                                                                                               2.1 DEPRESSION 
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symptoms persist for at least two weeks. However, the DSM-IV notes that these symptoms 
must persist "most of day, almost every day". In the ICD-10, only the symptom of depressed 
mood is required to be present almost every day and for most of the day (Kölch, Fegert & 
Freyberger, 2011, Gruenberg, Goldstein, Pincus, 2005). For clarity, the criteria of DSM-IV-
TR (Faumann, 2001) and ICD-10 (Dilling, Mombour, Schmidt, 2014) are contrasted in Table 
1.  
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Table 1.  
Diagnostic criteria of depression ICD-10. Adapted to Gruenberg, Goldstein, Pincus (2005); 
Dilling, Mombour, Schmidt (2014);  Faumann (2001).  
 ICD-10 DSM-IV-TR 
Symptoms Three major symptoms 
1. depressed mood most of the 
day and almost every day 
2. loss of interest and enjoyment 
of activities and listlessness 
3. increased fatigue 
 
In a mild or moderate depressive episode 
at least two of these symptoms must be 
present, in severe depression at least 
three  
 
Other symptoms 
4. loss of trust or self-esteem 
5. unfounded self-blame or guilt 
6. suicidal thoughts or actions 
7. concentrations problems or 
indecision 
8. psychomotor agitation or 
inhibition 
9. sleep disorders 
10. appetite loss or increase 
 
 
 
In mild depression, there must be at  
least two of these symptoms, three to 
four in a moderate, and at least four in a 
severe depression. 
Symptoms 
1. depressed mood most of the 
day and almost every day 
2. loss of interest or pleasure in 
all, or almost all, activities most 
of the day, nearly every day    
3. Feelings of worthlessness or 
guilt feelings that are 
inappropriate and excessive 
4. suicidal thoughts or actions 
5. concentrations problems or 
indecision nearly every day 
6. increased fatigue nearly every 
day 
7. psychomotor agitation or 
inhibition nearly every day 
8. sleep disorders  
9. appetite loss or increase every 
day / weight loss or weight gain 
 
 
 
 
There is no subdivision by severity  
The diagnosis of depression can then 
be given, if there are five or more 
symptoms. One of the symptoms is  
1) depressed mood or 2) loss of 
interest or pleasure . 
Clinical relevance Mild depression  
Despite the patient's experience of mild 
depression, he can fulfill his professional 
obligations and continue to participate in 
social life.  
 
Moderate Depression 
In the case of moderate depression, 
performing everyday activities is much 
more difficult for the patient. 
 
Severe Depression 
The patient is no longer able to carry out 
his day-to-day activities. 
There is no subdivision by severity 
The symptoms affect the person in 
social, occupational or other functional 
areas. The patient experiences this as a 
significant burden. 
  
 
Symptom duration  Mild or moderate depressive episode 
Symptoms must at least two weeks 
before the diagnosis can be given.  
 
Severe depression 
Diagnosis can be given earlier than two 
weeks, but this depends on the severity 
of the disease 
There is no subdivision by severity 
Symptoms must at least two weeks 
before the diagnosis can be given 
2 Background                                                                                                               2.1 DEPRESSION 
 16
 
2.1.4 The clinical picture of depression in DSM-5 
Depressive disorders are listed in the DSM-5 in the “new depressive disorders” section, which 
is separated from the “bipolar disorders” section. In the DSM-IV, this division did not exist, 
all illnesses listed in these two chapters were listed under the term mood disorders. Chronic 
disease and dysthymic disorders are listed in DSM-5 under the heading of persistent 
depressive disorders (Ehret, Berking, 2013; Uher, Payne, Pavlova, Perlis, 2014). The 
depression criteria have hardly changed from DSM-IV to DSM-5. The diagnosis of major 
depression can be given in the event of one depressive episode or multiple depressive 
episodes over the life course. For the diagnosis, five to nine symptoms must be present over a 
period of two weeks. Depressed mood or anhedonia (loss of interest or pleasure) is a symptom 
that must be present. Some of the DSM-5 symptoms of depression need to be present almost 
every day, while others are not (see Table 2).  
According to Uher et al. (2014), there are three changes in the DSM-V compared with the 
DSM-IV. The first change is the removal of the statement “that mood-incongruent delusions 
or hallucinations should not count toward the diagnosis of MDE/MDD”. The second change 
is that in the DSM-V the word hopeless was added. Thus far, only the word sad was listed 
here. The word "hopeless" deals with how a person perceives the future perspectives. The 
third change refers to the grief reaction, which was listed in DSM-IV but removed in DSM-V. 
The diagnosis of major depression should be well evaluated in bereavement because grief 
reactions may be confusingly similar to the symptoms of depressive illness (Ehret, Berking, 
2013; Uher, Payne, Pavlova, Perlis, 2014). Ermann (2007) states that despite being similar, 
the two constructs of depressive illnesses and grief reactions are based on completely 
different experiences. A person suffering from depression often revolves around him-/herself 
mentally, feeling an inner emptiness and is confronted with self-blame. However, a person 
grieving for a loved one feels incredibly sad but this does not affect their self-esteem. This 
difference must be taken into account when making the diagnosis. For clarity, the criteria of 
DSM-IV-TR (Faumann, 2001) and DSM-5 (American Psychiatric Association, 1994) in 
Table 2 are contrasted.  
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Table 2.  
 Diagnostic criteria of depression DSM-5 and changes from DSM-IV-TR. Adapted to Uher, 
Payne, Pavlova, Perlis (2014); Faumann (2001); American Psychiatric Association (1994).  
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2.1.5 Epidemiology of depression  
Depression is one of the most common mental illnesses and the risk of developing a 
depressive disorder is steadily increasing (Will et al. 2008; Wittchen & Hoyer, 2006). This 
statement is in line with the information provided by the WHO (2017), which wrote in a 
report from 2017 that an increase of 18.4 percent was recorded between 2005 and 2015. A 
total of 322 million people suffer from depression, which corresponds with 4.4 of the world 
population (WHO, 2017). According to the WHO, the prevalence rates vary depending on the 
world region (Figure 1). 
 
 
Figure 1. Cases of depressive disorders (millions) by WHO regions. Adapted to WHO (2017).  
 
The prevalence rate in women between the ages of 55 and 74 years is 7.5%, for men it is 5.5% 
(WHO, 2017). The fact that women are more likely to develop depression than men is evident 
across different countries (Andrade et al., 2003). Albert (2015) attributes these differences to 
different types of stressors. Women are more prone to disagreements in interpersonal 
relationships, which are mainly processed internally. Men, on the other hand, are more 
sensitive to performance stress at work (Albert, 2015; Bartels et al., 2013; Kendler & 
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Gardner, 2014). In addition, women are more likely to undergo hormonal changes during their 
lifetime this can lead to “premenstrual dysphoria, postpartum depression or postmenopausal 
depression” (Albert, 2015). Another reason that may be responsible for this is developmental 
differences in the cerebral circulation (Albert, 2015; Gillies & McArthur, 2010). Women who 
have no stable relationship with a partner or friend, has three or even more children younger 
than 14 years or whose mother died before the age of eleven are more vulnerable to the onset 
of depression. Likewise, single unemployed women seem also be at increased risk (Brown & 
Harris, 1978; Will et al., 2008). 
Approximately 12-26% of the adult population develops a moderate depression at some 
point in their lives (Will et al. 2008). The lifetime prevalence of depression, varies greatly, 
between 4% and 20%. These differences can be attributed to various factors such as “study 
population, used diagnostic criteria, survey response rates or methodological procedures” 
that can influence the study outcome. For example, depending on the country, it could be 
shown that the rate in Japan is very low at 3 percent, whereas in the US the rate is 16.9%  
(Andrade et al. 2003). The lifetime prevalence in Germany is 17.1 percent (Jacobi et al., 
2004). Between 2008 and 2011, 7,988 people in Germany were examined for a recent 
depression. The age of the examined persons lay between 18 and 79 years. In adults, 
depressive symptoms were 8.1%. Here, again the prevalence was higher in women (10.2%) 
compared with men (6.2%). It could also be shown that a higher socioeconomic status is less 
strongly associated with depression. According to this study, the 12-month prevalence is 6.0% 
(Busch, Maske, Ryl et al., 2013). Although depression can occur at any age, the risk of 
developing depression seems to be highest between the ages of 30 and 40 years (Will et al., 
2008). Andrade et al. (2003), on the other hand, indicates the average for onset of illness is 
between 20-25 years. According to Möller, Laux and Deister (2009), 10% of the people who 
present themselves in a general practice suffer from depression. In a cross-sectional 
epidemiological study from Beesdo-Baum, Knappe and Einsle (2018), it was examined how 
often depression is detected when patients present themselves in a general practice. For this 
purpose, 3,563 patients were examined on a fixed date in six different regions of Germany. 
For the investigation, the Depression Screening Questionnaire (DSQ) was used to raise 
mental and physical complaints. A medical diagnosis was made based on the ICD-10. 
According to the researchers' analysis, the ICD-10 depression reporting date prevalence was 
14.3% according to DSQ and 10.7% after a doctor’s diagnosis (Beesdo-Baum, Knappe, 
Einsle, 2018). 
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2.1.5 Types of depression measurement 
Since the effects of depression can be very serious in terms of private and professional life, a 
quick and accurate diagnosis is particularly important. According to Wittchen and Hoyer 
(2006), the “symptoms of depression, the severity of the disease and the temporal 
occurrence” should be recorded reliably and validly. Accordingly, the measurement accuracy 
should be high and an existing depression should be detected and not something else. In order 
to guarantee this, various questionnaires as well as structured interviews have been developed 
in the past. It is impossible to list all existing depression questionnaires here, as there are over 
a hundred of them (Kronmüller & Mundt 2000 as cited in Bouman, 1993). According to 
Kronmüller and Mundt (2000), the most common depression questionnaires are the Beck-
Depressions Inventar (BDI; Beck, Hautzinger, Bailer, Worall & Keller, 1995), Self-Rating-
Depression Scale (SDS; Zung, 1965) or the Allgemeine Depressionsskala (ADS; Hautzinger 
& Bailer, 1993).  
Due to the variety of questionnaires that are currently used in clinical practise, the question 
arises whether the results of the questionnaires are in fact all comparable. Questionnaires that 
are used to detect depression correlate on average by 0.69 (Kronmüller & Mundt, 2000 as 
cited in Bouman, 1993). Based on previous studies, Kronmüller and Mundt (2000) conclude 
that so far there is no questionnaire that can be fully recommended. Wittchen and Hoyer 
(2006) note that depression questionnaires often only capture the current severity of 
depression. However, according to the author, this is not always sufficient for the diagnosis of 
depression, as these do not allow differential-diagnostic conclusions. Therefore, the author 
advises using better structured or standardized clinical interviews. As an example of a 
structured clinical interview, he cites the SCID, which is based on the classification system of 
the DSM-IV. ("Structured Clinical Interview" for DSM-IV). It was shown that depression 
questionnaires and interviews correlate only moderately Kronmüller and Mundt, 2000. Both 
depression questionnaires and interviews seem to have disadvantages to minimize them and 
gain reliable diagnostic statements, the authors Katz's et al. (1995) suggestion is to use a test 
battery. In doing so, different survey instruments are to be combined with each other. For 
example, the SCID-I (Wittchen, Zaudig, Fydrich, 1997) could be used together with the 
HAM-D (Hamilton rating scale for depression; Hamilton, 1980). If the survey were based 
more on the classification system ICD-10, then the SCAN (Schedules for Clinical Assessment 
in Neuropsychiatry; Schützwohl, Kallert, Jurjanz, 2007) interview could be combined with
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the Inventory of Depressive Symptomatology (IDS, Rush 1986, 1996), for example. 
However, the authors also note that the combination of different diagnostic tools often results 
in new methodological problems. This problem cannot be solved in a satisfactory manner at 
present. 
2.1.6 Etiology of depression 
According to Bramesfeld and Stoppe (2006), depression is a disease that can be caused by 
many factors, whereby it is also called a multicausal event. Möller et al. (2009) divide the 
factors underlying the depression into three groups, whereby genetic factors, psychological 
factors and neurobiological factors may play a role in the development of depression.  
In their work entitled "Genetic Epidemiology of Major Depression: Review and Meta-
Analysis", Sullivan et al. (2000) conclude that the heritability of depression is approximately 
between 31% and 42%. In severe depression or recurrent depression, the probability of 
disease could be quite higher. Children whose parents are already suffering from depression 
have a much higher genetic risk. In addition to this, mental vulnerability factors could be 
detected much more often (Schulte-Körnke et al., 2008). Schulte-Körnke et al. (2008) state 
that children of depressed parents are exposed to a rather “passive, neglecting and repellent 
style of interaction“ and that these children perceive their parents as a “model for negative 
self-attribution, dysfunctional schemes, and low self-efficacy expectations”. In this context, 
the research team refers to Frye and Garber (2005) and Hammen et al. (2004). According to 
Wittchen and Hoyer (2006), there is both a passive and active gene-environment interaction. 
The passive gene-environment interaction is characterized by a greater vulnerability to 
uncontrollable life events. In the case of active gene-environment interaction, the probability 
that a depressive crisis event itself is caused is greater, such as a separation from a partner or a 
termination of an employment contract, etc.  
Among the psychological factors, Möller et al. (2009) first mention critical life events. 
According to the authors, depressive persons more frequently report that such an event has 
preceded depression. Critical life stories are always associated with a stress response: if such 
a period of stress lasts longer, then this can lead to an overload, which is reacted to through 
marked exhaustion or withdrawal from the social environment, in turn leading to depression.  
In terms of neurobiological factors, Möller et al. (2009) state that the imbalance between 
the neurotransmitters noradrenaline and serotonin is associated with depression. In persons 
suffering from depression, a deficit of these two neurotransmitters could be detected. Brain-
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based examinations have shown that the disease of depression is accompanied by 
morphological changes as well as an activation disbalance of different brain regions. The 
prefrontal cortex as well as the hippocampus seem to show a diminished substance and 
negative stimuli lead to an overactivation of the amygdala. Among the neurobiological 
factors, seasonal differences can also frequently occur in autumn/winter and lead to 
depression. The circadian rhythm in depressed people is often disturbed and the sleep phases 
are lower and less pronounced in depressives.  
Turning to neuroendocrinological research, depression is repeatedly associated and 
discussed with a thyroid disorder or dysregulation of the HPA axis (Möller et al., 2009).  
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2.2 Hypothalamic-pituitary-adrenal axis 
The HPA axis is also referred to as the stress axis. This axis enables healthy people to deal 
with stressful situations and adapt to them (Verdu, Hayes, O’Mahony, 2016). The following 
section describes the anatomy and physiology of the HPA axis and discusses the associated 
circadian rhythm. Subsequently, the manifold possibilities of cortisol measurements are 
described.  
2.2.1 Anatomy and physiology of the HPA axis 
The HPA axis is a system of three existing hormones, the corticotropin-releasing hormone 
(CRH), the adrenocorticotropic hormones (ACTH) and the cortisol (Abel & Hautzinger, 
2013). This finely tuned hormone cascade can be accomplished in several ways, by either 
internal stimuli such as pro-inflammatory cytokines or external stimuli such as stress (Goebel 
& Schedloski, 2008). 
The hypothalamus responsible for the release of CRH is located in the diencephalon and 
can be understood as a mediator between the nervous system and the endocrine system. This 
brain structure is particularly significant because it participates in a variety of physical 
processes and ensures that the body functions does not fall out of balance. As a command 
center, it regulates our basic needs such as hunger and thirst, the temperature of our body or 
our sleep-wake cycle. In addition, this structure acts as a controlling organ for our nervous 
system or our behavior in social contexts. The latter happens through the regulation of 
emotions. Furthermore, the production of various hormones is also controlled by the 
hypothalamus (Bley, Centgraf, Cieslik, Haack, Hohloch, 2015).  
The hypothalamus is connected to the pituitary gland, which is located in the base of the 
skull. This brain structure is divided into two distinct areas, namely the posterior and anterior 
pituitary lobes. For the function of the HPA axis, especially the anterior pituitary is important. 
In case of stress or physical exertion, the cortex and especially the limbic system stimulate the 
hypothalamus to release the CRH and the antidiuretic hormone (ADH) via serotonergic and 
cholinergic fibers (Rensing et al., 2006). These two hormones in turn stimulate the 
corticotropic cells of the pituitary gland to produce and release the adrenocorticotropic 
hormone (ACTH), which then enters the blood and is thus transported to the adrenal cortices 
(Bley, Centgraf, Cieslik, Haack, Hohloch, 2015; Hinson, Raven & Chew, 2018; Nicholson, 
2007).  
The adrenal cortices are located on the kidneys and can be divided into three different 
areas: the zona glomerulosa, zona reticularis and the zona fasciculata. The latter area is 
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responsible for the formation of glucocorticoids. One of the most important glucocorticoids is 
the hormone cortisol (Zeros-Kopp, 2007; Nicolson, 2008). In stress situations, this hormone is 
formed and ensured that the body has sufficient energy available. (Bley, Centgraf, Cieslik, 
Haack, Hohloch, 2015). The amount of cortisol in the blood is regulated by a complex 
interaction between the hypothalamus, pituitary and adrenal glands. Once released, the 
hormone cortisol enters into all parts of the body and back to the hypothalamus, where the 
amount of cortisol is controlled. The overshoot of a stress response is prevented by this 
negative feedback mechanism of the HPA axis (Hinson, Raven & Chew, 2018). An overview 
of this process is shown in Figure 3.  
 
 
Figure 2. Interactions of the HPA axis. Adapted to Kulkarni, Gavrilidis & Worsley (2016).  
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2.2.2 Cortisol circadian rhythm 
The release of the hormone cortisol is not only dependent on stress but is also subject to a 
circadian (Day-Night) rhythm. Between 6 o’clock and 9 o’ clock in the morning the serum 
cortisol values reaches its maximum (Hinson, Raven & Chew, 2018). According to Nicolson 
(2008), the highs depend on the personal waking times. The cortisol production increases 
rapidly after awakening and reaches its peak about 30 to 45 minutes later. From this on, the 
concentration gradually decreases over the day (Hinson, Raven & Chew, 2018) until it 
reaches its lows between 4 and 8 pm (Froesch, 1981). 
2.2.3 Types of cortisol measurement 
Cortisol can be measured in several ways. Nicolson (2008) lists various types of measurement 
in the Handbook of Physiological Research Methods in Health Psychology discusses the pros 
and cons of each technique. According to the author, the measurement of cortisol in urine is 
one of the oldest methods. This type of measurement is particularly suitable for determining 
the cortisol level at night. For some diseases are mainly changes in the night cortisol but not 
in the daily cortisol can be observed (Nicolson, 2008). For example, this applies to patients 
with panic disorder (Abelson and Curtis, 1996) or with a post-traumatic stress disorder 
(Yehuda, 2002). The free urinary cortisol levels are not affected by the circadian rhythm, so 
the "relative free cortisol concentrations in the peripheral circulation in one day" can be 
measured well (Gatti et al. 2009). For research purposes, Nicolson (2008) argues that urine 
measurements are rather inappropriate because an acute stress response cannot be detected 
and the participation in the study as well as adherence to the measurement procedure by the 
participants are often impaired. Furthermore, cortisol is a molecular structure that is very 
similar to other steroid metabolites, which can lead to problems in the evaluation. This 
problem can be significantly improved by the use of solvents, which extracts certain steroids 
but they are not completely removed (Gatti et al. 2009; Murphy, 1999, 2002). Sauve et al. 
(2007) conducted a study comparing urine cortisol samples and hair cortisol samples, finding 
only a weak correlation. Sauve et al. (2007) states that “urine represents cortisol secretion 
during one day, whereas hair cortisol levels represent levels during 1-2 months”. Haircortisol 
samples have several factors that need to be considered. Hair cortisol levels are lower in dyed 
hair compared with untreated hair. Haircortisol samples can only be taken if there is sufficient 
hair in the area of the posterior vertex. The detection of short cortisol responses or day-to-day 
variation is not possible.  
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Another possibility to determine the cortisol concentration of subjects would be the use of 
the dexamethasone suppression test. Dexamethasone is a glucocorticoid. If it is administered 
from the outside, it suppresses the cortisol release in the body. This is achieved via the 
already-described negative feedback mechanism (Piper, 2007). The cortisol measurement 
before and after the test can be conducted via either a saliva test or a blood sample. As a 
diagnostic test care must be taken in the event of depression (Nicolson, 2008; Carroll et al., 
1981). On the first day of the examination, 1 mg dexamethasone should be administered at 11 
p.m. and on the second day at 4 p.m. In addition, Nicolson (2008) noted that the concentration 
of cortisol samples is dependent on the dexamethsone dose: when taking more 
dexamethasone, then cortisol suppression will take longer. The removal of several saliva 
samples leads to more reliable results. The necessity for precise adherence to this procedure 
may be one reason for the test having been rarely been used in the studies, so Nicolson 
(2008). In stress situations, this test is unsuitable due to its sensitivity because it increases the 
risk of false test results. In persons with malnutrition, obesity, sleep problems, drug and 
alcohol withdrawal or depression, suppression of plasma cortisol may be absent after the 
administration of dexamethasone (Berger 1984, Beuschlein & Reincke, 2006). Arane et al. 
(1995) conducted a study in which she investigated whether the administration of 
dexamethasone is successful in the treatment of depression. The results of the study have 
shown that the administration of dexamethasone over 4 days of treatment is more effective 
compared with a placebo for 14 days. 
Measurements of cortisol levels in saliva are widely used today, due to the advantages this 
type of measurement entails. Cortisol is not bound in saliva, unlike in the blood, meaning that 
it is not bound to any carrier proteins such as corticosteroid-binding globulin (CBG). It is a 
non-invasive procedure that can be well used by the study participants at home can have a 
positive influence on participation in the study because it is stress-free. The fear of injection 
could be a criterion for refusing to study. In addition, the simple removal of the salivary 
cortisol makes it easier to obtain more samples from the participants. The cortisol samples can 
be obtained by either collecting the saliva in a plastic tube or using a salivette. The latter is 
more accurate in terms of the determination of total and free cortisol. Saliva cortisol 
measurements can be performed at any time of the day. A popular sampling time is shortly 
after waking up (Gatti et al., 2009; Nicolson 2008; Vining et al., 1983). Although a 
relationship between salivary cortisol samples and serum cortisol samples could be 
demonstrated (Sauve et al., 2007), there are some differences between these two types of 
measurements. Compared with the decrease in serum, the absolute level of free cortisol in 
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saliva is about 10% to 35% lower. It has been shown that cortisol response is weaker 
following awakening than in saliva. Serum cortisol returns more quickly to baseline after 
stress (Nicolson, 2008). 
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2.3 Neuroendocrinological changes in depression  
2.3.1 HPA axis in depression  
Pariante and Lightmann (2008) write in their review entitled "The HPA axis in major 
depression: classical theories and new developments":  
 
“HPA axis hyperactivity is not a simple consequence or an epiphenomenon of depression, but 
on the contrary that is a risk factor predisposing to the development of depression, brought 
about by early life experiences programming molecular changes as well as by genetic 
liability”. 
  
According to Pariante (2006), there are two different corticosteroid receptors. The 
mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). These two receptors 
differ in their affinity; The MR is affine for endogenous corticosteroids, whereas the GR is 
affine for dexamethasone. According to Roth et al. (2018) mineral corticosteroids are 
particularly important for the regulation of the salt-water balance in the body. The 
mineralocorticoids are regulated via the renin-angiotensin system as well as via the calcium 
concentration in the plasma. Glucocorticoids, on the other hand, are important for the 
intermediary metabolism, and their regulation takes place via the hypothalamic pituitary 
system. Based on the existing research situation, it can be assumed that the GR-mediated 
negative feedback is impaired in depressive people, but the MR mediated negative feedback 
intact (Juruena et al., 2005; Pariante, 2006). According to Pariante and Lightman (2008), the 
GR plays an important role in depression. Spilled cortisol in the body can bind to those 
receptors that have their seat either outside the brain (e.g. in the pituitary) or in the brain itself 
(e.g. hippocampus or hypothalamus). This compound regulates HPA axis activity and inhibits 
cortisol release. It is assumed that this "GR-mediated feedback inhibition" in depression does 
not work as usual. The GR activity can be influenced by environmental influences e.g. 
through a previously experienced trauma or indirectly by inflammatory processes. According 
to Wang et al. (2004), via the P38 mitogen-activated protein kinase pro-inflammatory 
cytokines can reduce the GR function. Pariante and Lightman (2008) assume that the 
overactivation of the HPA axis in depressive individuals reflects previous critical stressful life 
events. 
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2.3.2 Cortisol secretion in depressed adults 
In recent years, researchers have repeatedly been concerned with the question whether there is 
a dysregulation, of the hypothalamic-pituitary-adrenal axis in depressed people. Already in 
1984, Claustrat and colleagues examined a total of eleven patients suffering from depression 
regarding their cortisol levels and compared them with the values of healthy volunteers. The 
evaluation of the results showed increased mean plasma cortisol levels in the group of persons 
with depression. Carroll et al. (1976) found that daily urinary free cortisol values are 
particularly high in patients with a depressive disorder. In people with neurotic depression, 
cortisol levels were not as high as in people with unipolar depression. The values in patients 
with unipolar depression were comparable to the values of people with Cushing's syndrome.  
According to a systematic review by Staufenbiel et al. (2013) an increased cortisol 
concentration could be detected in the hair of depressive people. Bhagwagar et al. (2005) also 
showed higher cortisol levels in depressive subjects. They used awakening cortisol and 
compared the values of those with depression to those of healthy ones. Cortisol levels were 
25% higher in subjects with severe depression than control subjects. The studies listed here 
show that the cortisol levels in depressed people are changed compared with healthy people 
and that the same results are repeatedly obtained regardless of the type of cortisol 
measurement,. 
In a meta-anaylsis, Burke et al. (2005) examined the stress response of the HPA axis in 
healthy and depressed people. In addition, the researchers were interested in how the response 
of the HPA axis behaves after the loss of the stressor. The evaluation of the results showed 
that depressives and healthy people differ in their stress response. The stress response of 
depressed is not as pronounced and the recovery is impaired. Depressed individuals thus the 
authors "exhibit a relatively flat and unresponsive pattern of cortisol secretion". The 
researchers highlight that this pattern is consistent with previous work by Carroll and Mendels 
(1976) and Young et al. (1994), where a flattened daily activity (i.e. lower morning cortisol, 
higher afternoon cortisol) in terms of cortisol in depressives compared with healthy subjects 
could be shown. 
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2.3.3 Cortisol a potential biomarker for depression 
Thus far, the diagnosis of a depressive disorder is solely based on clinical examination. 
Taking into account the diagnostic criteria, the resulting subjective assessment of the 
examiner determines whether a person is depressed or not (Gross, 1982). A subjective 
assessment is always error prone. A major challenge of the 21st century is to identify 
biological features that can be used to diagnose or predict a psychiatric disorder, such as a 
depressive disorder (Pratt & Hall, 2018). Such biological features are also referred to as 
biomarkers. The Biomarkers Definitions Working Group (2001) defines the term biomarker 
as follows:  
 
“a characteristic that is objectively measured and evaluated as an indicator of normal 
biological processes, pathogenic processes, or pharmacologic responses to a therapeutic 
intervention.” 
 
In the past, risk factors could be identified that play a role in the onset of depression, such as 
age, gender, level of education, previous depressive episodes or familial predisposition (King 
et al., 2008). In the article "Suggested Biomarkers for Major Depressive Disorders," 
Hacimuscular (2018) identifies potential biomarkers of depression including “serum and 
plasma BDNF, serum IL-1, IL-6, TNF and peripheral RNA expressions, MDA, SOD , Leptin, 
ghrelin, 5-HT transporter mRNA in blood, hippocampus volume, HPA activity, cortisol 
response to DEX / CRH”. Whether or not cortisol – as a biological regulator of HPA activity 
– can be a biological indicator of depression has not yet been conclusively clarified. However, 
a biological indicator could help to identify individuals at risk of depression and initiate early 
treatment. The fact that a variety of studies have shown that depression is associated with 
altered cortisol levels has led researchers to investigate whether cortisol is a potential 
biological risk factor regarding the onset of depression. The results of the existing studies are 
very different: some studies have shown that cortisol is a predictor of depression (e.g. 
McKinney et al 1997, Pinna et al., 2014, Harris et al., 2000, Herbert et al., 2012, Nabeta et al. 
2014, etc.), whereas in other studies this could not be proven (e.g. Akbaraly et al. 2013, 
Vammen et al. 2014, Vinberg et al. 2014, etc.). It is legitimate to ask why an association 
between cortisol and depression could be found in some studies and not in others. It may be 
that these differences are due to the different methods of measuring cortisol or the different 
types of depression survey instruments used. Another reason could be the different measuring 
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times when determining the cortisol values. In addition, other factors such as age or gender, 
etc. could naturally play a role. In order to ascertain this, a detailed investigation of the 
available study results is necessary. 
2.4 Research question 
In this work, it will be examined whether aberrant cortisol levels are prognostic factors for the 
development of depression in the adult population And if yes, whether certain ways of 
cortisol measurements (salivary, urine, hair, serum) and times and modes of sample taking 
(awakening cortisol, morning cortisol, evening cortisol, cortisol profiles, DEX-CRH-rest) 
could be recommended for clinical practice in a pragmatic way.  
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3 Methodology  
3.1 Selection of studies and data extraction  
Designs of the primary studies were prospective to examine the predictive value of cortisol 
status for the development of depression in the cohorts of healthy adults. All studies of the 
peer-reviewed literature using different databases (Pubmed, PsycInfo, Medline and Embase) 
with the predefined search terms listed in Appendix A, grey literature, hand search and expert 
consultation were verified. Two independent reviewers (Daniela Stotz and Mareike Stieg) 
screened titles and abstracts of the studies for the relevance and suitability, while a third 
reviewer (Caroline Sievers) resolved disagreements. Data extraction was performed 
simultaneously by two researchers (Daniela Stotz and Susanne Kirchner). Studies were 
included according to the PRISMA four-phase flow diagram. Included studies were examined 
and selected according to study design, participants, intervention, data collection, data 
analysis, results and relevant contextual information. The results of the two researchers were 
compared and discussed afterwards to validate and standardize the data. The protocol for this 
study is published under prospero. 
3.2 Inclusion criteria  
Observational studies; prospective cohort studies with a minimum length of 6 weeks; studies 
from 1992 to 2015; studies in which depression is measured at two time points.  
3.3 Exclusion criteria  
Case reports; studies with reports in another language than English; systematic reviews or 
meta-analysis; studies including subjects with a lifetime diagnosis of psychotic disorder; 
studies with subjects receiving antidepressant treatment; subjects with medications that 
interfere with cortisol metabolism; subjects using with hormone replacement therapy 
including oral estrogens.  
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3.4 Study population  
The study population comprised adults ≥ 18 years of age with measured cortisol levels and 
measures of depression, analyzed in prospective cohort studies between 1992-2015 or adults 
with a remitted depression. Patients in remission were stable for at least 6 months without 
taking antidepressants. The intervention is the cortisol assessment as a prognostic test. The 
outcome of this review is the occurrence of depression or symptoms of depression. It was 
defined according to ICD-10 criteria (first appeared 1992, released by the WHO), DSM-IV 
criteria (first appeared 1994; released by the American Psychiatric Association in 2013) or 
DSM-V (first appeared 2015), which are internationally established diagnostic frames. The 
outcome variable was measured by standardized depression rating scales. Both self-report 
depression scales such as the BDI or the Center for Epidemiologic Studies Depression Scale 
(CES-D) and depression scales completed by the researcher such as the Hamilton Depression 
Scale (HAM-D) or the Structural Clinical Interview (SCID-I) were allowed. Predictors and 
outcomes are listed in Table 3. 
Table 3.  
Predictors and Outcomes. 
Hormone of 
interest 
Neuroendocrine 
axis 
Context of interest Disease of interest 
Salivary cortisol 
Urinary cortisol 
Hair cortisol 
Serum cortisol 
CRH Test 
DEX-CRH Test 
Hypothalamic-
pituitary-adrenal axis 
Mental health Major Depressive 
disorder 
Dysthymic Disorder 
Depressive symptoms 
Adjustment disorder 
Suicide in Depression 
 
3.5 Assessment of study quality  
Quality of primary studies were assessed by using the quality appraisal tool “Newcastle 
Ottawa Scale” (Appendix B) for observational studies and “Jadad Scale” for interventional 
studies (Appendix C).  
3.6 Newcaste-Ottawa Scale  
This scale evaluates the studies in terms of three different aspects: selection of study groups, 
comparability of study groups and outcome of interest. The assessment is based on a star 
rating system. For the selection of study groups, the maximum number of stars is four, the 
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comparability of the studies received one star and the outcome a total of three stars. 
Therefore, a maximum of eight stars can be awarded. 
3.7 Jadad Scale  
This scale was used to assess the quality of interventional studies. This is used to assess the 
studies in terms of three different domains: randomization, double blinding and description of 
withdrawals and dropouts. For the description of the randomization, one point is awarded if it 
is mentioned and two if it is described and appropriate. For the description of double blinding, 
one point is awarded for mentioning and two if it is described and appropriate. The 
description of withdrawals and dropouts is rated with one point if described. Thus, maximum 
number of points to be achieved is five. 
3.8 Search of studies  
By combining key words (Cortisol OR DEX/CRH OR "HPA axis") AND (Depression OR 
Depressive Disorder OR Adjustment Disorder OR Suicide) we found 10,673 appropriate 
articles. After filtering duplicates, 4,619 articles in English language remained. We included 
all studies where the correlation between cortisol levels and depression has been examined 
and which met all inclusion criteria and none of the exclusion criteria. Overall we included 41 
studies in our systematic review. Of these 17 were observational studies and 24 interventional 
studies (Figure 4). 
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Figure 3. Information PRISMA flow chart during study search and selection.  
4 Results 
4.1 Patient characteristics  
Table 4 shows information about the first authors’ location, population, study design, total 
number of participants, sex, age at baseline, follow-up and funding of the 41 studies included. 
The total number of participants of all 41 studies was 20,006, their age ranging from 18 to 96, 
and the follow-up time laid between one month and nine years. Eleven studies were from the 
UK, eight from the US, four from Sweden, three each from Denmark and the Netherlands, 
two each from Canada, Japan and Germany and one each from Italy, France, Switzerland, 
Spain, Australia and Belgium.  
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Table 4.  
Patient characteristics.  
 
4 Results                                                                                                                                                                                       4.1 PATIENTS CHARACTERISTIC 
 
 37
 
 
 
4 Results                                                                                                                                                                                       4.1 PATIENTS CHARACTERISTIC 
 
 38
 
 
 
 
 
 
4 Results                                                                                              4.2 OBSERVATIONAL STUDIES                                   
 
 39
4.2 Observational studies  
In Table 5, all included observational studies are listed. In total, seventeen observational 
studies were evaluated. Although cortisol and depression values were measured in all 
observational studies, seven studies did not report their association. In five studies no 
correlation could be found and in another five studies the outcome was dependent on other 
factors, such as the time of cortisol collection or gender.  
A positive correlation could be found in four studies. Two of these studies are identical 
with respect to all parameters (Harris et al. 2000; Herbert et al. 2012). In these two studies it 
could be shown that salivary cortisol levels taken in the morning were positively associated 
with depression. Herbert et al. (2012) found to be an exact U-shaped relationship between 
adjusted salivary morning cortisol levels at baseline and the probability of depression onset 
during the follow-up. In addition, Harris et al. (2000) also provided that cortisol levels taken 
in the evening were not associated with depression. It is important to mention that both 
research teams only examined women. Herbert et al. (2012) even investigated menopausal 
women. The salivary cortisol level was measured on several consecutive days. No statement 
was made as how long the participants were already awake at the time of taking the salivary 
cortisol samples. In the following the study parameters: Harris et al. 2000: salivary, 8 o’clock 
in the morning and evening, SCAN interview, mean age 38.5, follow-up 13 months; Herbert 
et al.: salivary, 8 o’clock in the morning, SCAN interview, mean age 36.8, follow-up 12 as 
well as 18 months.  
These results are in line with the results of two other studies. In one study, a positive 
association was found for women when the salivary cortisol samples were determined 
between 1 and 4 pm (Nabeta et al., 2014) and in the other study when the salivary cortisol 
samples were taken three hours after awakening (Geoffrey et al., 2013). Cortisol levels were 
determined in a single day. For men, Nabeta et al. (2014) found no association and Geoffroy 
et al. (2013) prove a negative correlation. In men with a low cortisol level at the age of 45, 
depressive symptoms are more likely at the age of 50 years. These studies differ regarding the 
depression diagnostic tool used, the age and the follow-up time: Nabeta et al. 2014: BDI, 
mean age 73, 36 months; Geoffrey et al. 2013: MHI-5, mean age 45, 60 months.  
Grynderup et al. (2013) also found a negative correlation. The research team studied a 
mixed cohort, in which men and women were not considered independently. Concerning the 
type of cortisol measurement, time of measurement and the type of depression measurement 
the study is similar to that of Harris et al. (2000) and Herbert et al. (2012). The exact time for 
the morning salivary cortisol determination was 30 min after waking up and all samples 
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collected up two hours later were accepted. The determination of the cortisol level took place 
in a single day. For cortisol levels after awakening and in the evening, the research team could 
not find an association. However, the risk of depression increases by increasing daily mean 
cortisol concentration and by increasing morning-to-evening slope. Grynderup et al. (2013) 
refers in his article to the Harris et al. (2000) study and notes the differences between his and 
the Harris study to several factors. The participants of Grynderup et al. (2013) were more 
educated, all were employees had a much less history of depression and were not selected 
because they were likely to develop depression. What Grynderup et al. (2013) does not 
address is that Harris et al. (2000) studied only women. In the following the study parameters 
of Grynderup et al. (2013): salivary; morning, evening, profile; SCAN interview, age between 
35 and 55 years, follow-up 24 months. 
In five studies, no correlation could be proven. Salivary cortisol-awakening samples were 
collected in two of these five studies (Vammen et al. 2014, Vinberg et al. 2014). In the 
remaining three studies, the researchers used all serum samples (Akbaraly et al., 2013, 
Kalmijn et al. 1998, Kuningas et al., 2007), while the dexamethasone test was used in one 
study (Kalmijn et al., 1998). In all of these studies, mixed cohorts were studied. In the 
following the exact study parameters: Vammen et al. (2014): salivary, awakening and evening 
on a single day, SCAN interview, age between 109 and 66, follow-up 24 months; Vinberg et 
al. (2014): salivary, awakening and evening, SCAN interview, mean age 44 years, follow-up 
108 months; Akbaraly et al. (2013): serum, awakening, profile, CES-D, mean age 60.6 years, 
follow-up 60 months; Kalmijn et al. (1998): serum and dexamethasone, CES-D; mean age 
67.3 years, follow-up 22.8 months; Kunings et al. (2007): serum, morning, GDS-15, mean 
age 85 years; follow-up 50 months. ) 
4.2.1 Quality of observational studies  
The assessment of the individual studies is listed in Table 3. As the evaluation shows, the 
ratings of most studies range from four to six stars out of the maximum of eight stars 
according to the Newcastle-Ottawa Scale. Only one study by Houtveen and Doornen et al. 
(2008) was rated with three stars.  
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Table 5.  
Observational studies.  
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NR = not reported, o = no association, - = negative association, + = positive association 
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4.3 Interventional studies 
In Table 6, all included interventional studies are listed. We identified 24 studies in which 
cortisol and depression values were determined. In nineteen studies, cortisol was not 
examined as a predictor of depression, although all relevant values were collected. In five of 
the remaining studies, the association between cortisol and depression was investigated and 
reported. Of the total of five studies in which a relationship has been reported, there are no 
studies consistent with all parameters such as type of cortisol measurement, time of taking 
blood, and diagnostic instrument of depression. A positive correlation could be found in two 
studies (McKinney et al., 1997, Pinna et al., 2014). Mc Kinney et al. (1997) investigated 
healthy adults in a randomized trial of Bonny Method of Guided Imagery and Music sessions 
and their effects on mood and cortisol. The research team concluded that a pre-test to the 
follow-up decrease in cortisol was significantly associated with a decrease in mood 
disturbance. Pinna et al. (2014) examined 95 people who had a total replacement of their knee 
joint and found that higher cortisol levels are associated with a greater risk of depression at 
one and three months following surgery. Apparently, this effect was stronger for men than 
women at one month following surgery but did not differ between genders at three months 
post-surgery. The selected study parameters differ and were as follows: Pinna et al., 2014 
urinary, profile, CES-D, mean age 69.25; follow-up 1 and 3 months and Mc Kinney et al. 
1997: serum, morning, POMS, age 23-45, follow-up 1.5 and 3 months. 
In three studies, no association between cortisol and depression was found. Filaire et al. 
(2001) studied male soccer players and stated that no statistically relevant correlations were 
found regarding hormonal states and mood states. However, the researchers do not indicate 
which correlations were calculated exactly. Thus, an exact evaluation of the study is not 
possible. The study parameter was as follows: salivary; awakening, noon, afternoon; POMS, 
mean age 23.7, follow-up 3, 4 and 8 months.  
Matousek et al. (2011) conducted a study with female participants of a mindfulness-based 
stress reduction program having undergoing breast cancer treatment. The participants were 
assessed for stress, depressive symptoms and somatic (e.g. gastrointestinal, respiratory, pain) 
and psychosocial symptoms (e.g. difficulty in relaxing, sexual difficulties”). The researchers 
found that the area under the curve (AUC) cortisol-awakening response is negatively 
correlated with the change in somatic symptoms. They found no association between the 
AUC cortisol response after awakening and the depressive symptoms. The study parameter 
was as follows: salivary; awakening, CES-D, mean age 55.9, follow-up 2 months. 
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Liebermann et al. (2012) who examined also only women could find no association 
between cortisol and depression. The women participated in an intense twelve-week physical 
and mental training. In addition to a variety of biomarkers, the predictive relationship between 
cortisol and depression was also investigated. They found that eleven biomarkers did not 
predict at least two Profile of Mood States (POMS) questionnaire parameters, one of them 
cortisol. Liebermann was the only one who used plasma cortisol samples. In the following the 
study parameters: plasma, morning, POMS, mean age 19,3, follow-up 3 months).  
4.3.1 Quality of Interventional studies 
The assessment of the individual studies is listed in Table 4. As the evaluation shows, the 
ratings of most studies range from zero to four out of a maximum of five points. 
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Table 6.  
Interventional studies.  
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NR = not reported, o = no association, - = negative association, + = positive association  
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5 Discussion 
In this systematic review, 41 observational and interventional studies were evaluated 
regarding the question whether aberrant cortisol levels are a prognostic factor for the 
development of depression in the adult population. The picture that emerges from the 
interventional studies is inconclusive. Only two out of the total 24 interventional studies 
reported a positive association between cortisol and depression (McKinney et al. 1997; Pinna 
et al., 2014); and no association could be demonstrated in three studies (Fialire et al., 2001; 
Liebermann et al., 2012; Matousek et al., 2011). Due to the small number of studies in which 
an association has been reported and the fact that there are almost no interventional studies 
that can be compared regarding the parameters used (methods of cortisol measurement, 
timepoints and conditions, screening instrument for depression), a statement is impossible 
here.  
The observational studies provided a different picture, whereby only ten of the total 
seventeen observational studies examined reported a correlation. In five studies, no 
correlation could be found (Vammen et al., 2014; Vinberg et al., 2014; Akbaraly et al., 1998; 
Kuningas et al., 2007). And in one study, the risk of depression has been shown to increase by 
increasing daily mean cortisol concentration and morning-to-evening slope (Grynderup et al.). 
A total of four observational studies reported a positive association. Higher morning cortisol 
levels in women tend to be a predictor of depression (Harris et al., 2000; Herbert et al., 2012; 
Nabeta et al., 2014; Geoffroy et al., 2013). In men, the findings are unclear. In one study, no 
association was found between cortisol and depression (Nabeta et al., 2014), whereas in 
another study it could be shown that men with lower morning cortisol levels are at risk of 
developing depression (Geoffroy et al., 2013). In healthy men and women, the cortisol levels 
are usually indistinguishable (Bangasser et al., 2014; Uhart et al., 2006; Kirschbaum et al. 
1999). In women who are suffering from depression, higher cortisol levels can be detected 
compared with men (Bangassser et al., 2014, Young et al., 1995; Young et al. 2004). This 
difference is most pronounced after stressful and other negative live events (Bangasser et al., 
2014; Peeters et al., 2003; Chopra et al. 2009). Overall, women have a more susceptible HPA 
axis than men, which slowly returns to baseline after stress (Seidler, Freyberger & Maercker, 
2015). Cortisol release in women is cycle-dependent and may be influenced by the use of a 
contraceptive. In women in the folic phase and in those who take an oral contraceptive, a 
lower cortisol release could be detected (Kudielka & Kirschbaum, 2005). Whether taking 
contraceptives has an effect on the cortisol level or not depends on the type of cortisol 
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measurement used. Thus, after a three-month contraceptive use a higher basal and ACTH-
stimulated serum cortisol was found while the basal and stimulated salivary cortisol was not 
affected (Šimunková et al., 2008). The majority of the studies listed here did not mention 
whether female participants took oral contraceptive or in which phase of the cycle the women 
were at the time of the examination. This minimizes the informative value of the studies.  
A main task of this systematic review was to ascertain which methods of cortisol 
measurement, (salivary, urine, hair and serum), which timepoints and conditions (awakening 
cortisol, cortisol profiles, DEX-CRH tests) and which screening instrument for depression 
should be used to clarify whether different cortisol levels predict depression. The examination 
of the types of cortisol measurement shows that serum measurement and measurement of 
salivary cortisol has been used most frequently. However, only in one study an association 
between serum cortisol and depression could be demonstrated (Mc Kinney et al., 1997). 
Whereas in studies in which salivary cortisol was determined more frequently, a positive or 
negative association could be detected. As already mentioned, salivary cortisol samples offer 
some advantages compared with serum cortisol samples: obtaining specimens is very easy, it 
is a non-invasive procedure, it is not bound to any carrier proteins, etc. (Nicolson, 2008). For 
reliable results, salivary cortisol values should be measured on at least three consecutive days 
(Segerstorm et al., 2014). Not all of the studies listed in our systematic review have followed 
the recommendation. For example, in some studies the measurements took place over four 
days or even longer (Harris et al., 2000; Herbert et al., 2012) and in other studies, cortisol 
levels were measured on a single day (Geoffroy et al., 2013; Nabeta et al., 2014). 
Regarding the time of cortisol determination, the evaluation of the results suggests that 
morning cortisol is most predictive in determining the association between cortisol and 
depression. However, it should be noted that the studies we examined in the course of 
preparing this systematic review did not clearly differentiate between awakening cortisol and 
morning cortisol. For example, Grynderup et al. (2013) stated in his study that they measured 
morning cortisol of the participants. The subjects should take the cortisol sample 30 minutes 
after awakening. However, the researchers accepted all samples collected within 2 hours of 
awakening. In two other studies, the cortisol samples were taken at eight o’clock in the 
morning. However, no statement was made as how long the participants were already awake 
at this time (Harris et al., 2000; Herbert et al.2012). Geoffroy et al. (2013) took the samples 
45 min after awakening and 3 hours later and they found a positive association for the late 
morning cortisol for women and for men a negative association. For the cortisol-awakening 
response, although the researchers found no association. The level of cortisol-awakening 
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response is dependent on several factors. Pain, exhaustion, socioeconomic factors, social 
status or material living standards make the awakening cortisol response lower (Kumari et al., 
2009; Fabian et al., 2009; Wright et al., 2005; Ranjit et al. 2005) whereas acute stress leads to 
an increased awakening cortisol response (Stalder et al. 2016). According to Pruessner et al. 
(1999) perceived stress correlates with increased cortisol levels while burnout correlates with 
low cortisol. The latter could be related to the pronounced exhaustion, but this has not yet 
been sufficiently clarified. Kudielka and Kirschbaum (2003) found that the age and health 
status seem to have an impact on cortisol-awakening response. Furthermore, the feelings of 
the previous day, such as loneliness, sadness, threat and lack of control, may also increase the 
cortisol-awakening response the next day (Adam et al., 2006). Whether it comes to an 
awakening response and how this fails depends not only on these factors or the awakening 
alone but especially the timepoint of awakening. A study with nurses shows that the cortisol-
awakening response reaches the peak 60 minutes after getting up when the getting up time is 
between 4 and 5:30 in the morning. However, if the time of getting up is between 6 and 9 
o’clock in the morning or between 11 and 14 o’clock, the peak is already reached after 45 
minutes. The fact that the cortisol-awakening response can be influenced by so many factors 
suggests the question of whether this type of measurement is appropriate for determining the 
association of cortisol and depression. For our systematic review, we found two observational 
studies (Vammen et al., 2014; Vinberg et al. 2014) and two interventional studies (Filaire et 
al., 2001; Matousek et al., 2011), in which the cortisol-awakening response and the 
association between cortisol and depression were determined. In all four studies, no 
correlation could be found. In addition to the studies from our systematic review, we were 
able to find two studies in which it was investigated whether the cortisol-awakening response 
in adolescents is a risk factor for the development of depression. In one study, this could not 
be confirmed (Carnegie et al., 2014), whereas in the other study, the researchers came to the 
conclusion that the magnitude of the cortisol-awakening response is predictive for the onset of 
depression (Adam et al. 2010). In the latter study, the researchers note that their study differed 
from the previous studies in which no association could be found. Adam et al. (2010) took the 
cortisol values of their participants not at a specific time but the personal waking times. As 
already mentioned, in the studies of our systematic review the personal waking time was not 
sufficiently considered. And a clear separation between the cortisol-awakening response and 
the morning cortisol levels has not occurred. Based previous data showing by how many 
factors the cortisol-awakening response can be influenced, this should be taken into account 
in further investigations. This would increase the validity in terms of determining the 
5 Discussion 
 52
association between cortisol and depression. In any case, the salivary morning cortisol or the 
salivary awakening cortisol response was most studied as evidenced by the evaluation of our 
studies.  
Based on the data in our systemic review, it seems likely that the choice of diagnostic tool 
for depression is not critical in determining the association between cortisol and depression. 
In the four observational studies that reported a positive association for women, different 
diagnostic tools were used. In two of these studies the SCAN interview was used (Harris et 
al., 2000; Herbert et al., 2012) in one study the Mental Health Inventory MHI-5, a brief 
questionnaire was used (Geoffroy et al., 2013) and in the other the BDI, a self-reporting 
questionnaire (Nabeta et al., 2014). Our assumption is supported by three additional studies 
not included in our systematic review in which adolescents were examined. In all three 
studies, researchers concluded that higher salivary cortisol levels increase the risk of 
depression. However, these studies differed regarding the diagnostic instruments used. In two 
studies, the Mood and Feeling Questionnaire was used (Goodyer et al., 2000; Halligan et al., 
2007) whereas one study used a semi-structured psychiatry interview, the Schedule for 
Affective Disorders (Goodyer et al., 2010).  
As in all systematic reviews, the statements in our work depend on the quality of the 
studies available to us. As the study quality evaluation using the Newcastle-Ottawa Scale and 
the Jadad Scale shows, the quality of the observational studies was rather mediocre and the 
quality of the interventional studies was mostly between zero and two, and only three studies 
received a three and one study a four. Of course, this quality of the studies significantly 
reduces the informative value. As our systematic review shows, cortisol is a very susceptible 
hormone that can be affected by various factors. According to Nicolson (2008), these may be 
age, gender, ethnicity, somatic changes or illnesses, medication. Moreover, daily changes 
regarding the eating behavior, smoking or the individual sleep pattern can also affect the 
cortisol values. Such factors were only partially controlled or were not controlled at all in the 
studies included in this systematic review. Hence, we cannot judge the extent to which the 
results were influenced by such factors. As already mentioned, the examination of the 
individual studies showed that different measurement methods were used concerning 
measurements and tools for assessing depression. Similarly, the timepoints in time for 
measuring cortisol varied. 
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6 Conclusion 
In conclusion, our systematic review provides evidence that cortisol measurements may be a 
future candidate to be used as additional indicator in the prediction of depression in women. 
In men, the current insufficient research situation does not allow specific statements. 
However, the reliability of the results depends on a number of factors. Salivary cortisol 
appears to be the best method in terms of assessing the risk for the development of 
depression. The use is easy and our systematic review has shown that this type of 
measurement provides robust results. Regarding the timepoint, the awakening response and 
the morning cortisol are physiologically the most promising timepoints. However, we could 
not find any results for the awakening cortisol response in respect to the association between 
cortisol and depression. Most probably because awakening cortisol response is influenced by 
many factors such as age, stress, etc. Morning cortisol could be a more stable parameter, 
although this cannot be conclusively stated based on the existing data. The diagnostic tool for 
depression diagnosis was not crucial in the investigating studies. For a better comparison with 
current studies, we recommend using depression diagnostic tools that have been successfully 
used in determining an association between cortisol and depression, i.e. self-rating tools like 
the Mental Health Inventory, the BDI, Mood and Feeling Questionnaire or interviews like 
Schedule for Affective Disorders or Schedules for Clinical Assessment in Neuropsychiatry. 
For a reliable statement, further studies should be carried out, in which the waking times of 
the participants are considered and stated and in which the samples are collected on three 
consecutive days. Since cortisol is a very sensitive parameter, factors such as gender, age, 
illnesses, stress, medication contraceptive, eating behavior, smoking and individual sleep 
should be controlled to allow for a general recommendation and prospective use of cortisol as 
a predictor of depression. 
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Appendix A. Detailed search syntax, PubMed, PsychInfo, Medline, Embase. 
 Pubmed 
(Cortisol OR DEX/CRH OR "HPA axis") AND (Depression OR Depressive Disorder OR Adjustment 
Disorder OR Suicide) 
 
PsycInfo 
(Cortisol OR DEX/CRH OR "HPA axis") AND (Major Depression OR depression OR depressive 
disorder OR Adjustment Disorder OR Suicide) 
 
Medline  
(Cortisol OR DEX/CRH OR "HPA axis") AND (Depression OR Depressive Disorder OR Adjustment 
Disorder OR Suicide) 
 
Embase 
(Cortisol OR DEX/CRH OR "HPA axis") AND (Depression OR Depressive Disorder OR Adjustment 
Disorder OR Suicide) 
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Appendix B. Newcastle - Ottawa Quality Assessment Scale Cohort studies.  
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Appendix C. Jadad Score Calculation.  
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